Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04723732Completed
Randomised, triple-blind trial in gingivitis and dental plaque (3 arms), sponsored by King Abdulaziz University. Primary endpoint: Change from Baseline in inflammation on the proinflammatory interleukin (IL)-1beta biomarker at Day 14. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04723732.